Clinical Trial Update: Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is investigating whether immediate allogeneic hematopoietic stem cell transplantation is more effective than a bridging therapy foll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: RECRUITING